Oliveira, R. J. S., Silva, V. A. O., Martinho, O., Carloni, A. C., Melendez, M. E., Rosa, M. N., . . . Reis, R. M. (2016). Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker.
Chicago Style (17th ed.) CitationOliveira, Renato José Silva, et al. Cytotoxicity of Allitinib, an Irreversible Anti-EGFR Agent, in a Large Panel of Human Cancer-derived Cell Lines: KRAS Mutation Status as a Predictive Biomarker. 2016.
MLA (8th ed.) CitationOliveira, Renato José Silva, et al. Cytotoxicity of Allitinib, an Irreversible Anti-EGFR Agent, in a Large Panel of Human Cancer-derived Cell Lines: KRAS Mutation Status as a Predictive Biomarker. 2016.
Warning: These citations may not always be 100% accurate.